We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Short- and Long-term Group Psychotherapy (KOLG-P)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00521417
First Posted: August 27, 2007
Last Update Posted: May 2, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Brigham Young University
Information provided by (Responsible Party):
Steinar Lorentzen, University of Oslo
  Purpose
A primary goal of this study is to investigate the significance of treatment duration, by comparing change after group psychotherapy of varying lengths. A secondary goal is to investigate the predictive value of selected patient variables on outcome: personality pathology, quality of object relations, presence of personality disorder, degree of initial disturbance, and education. One hundred and twenty patients from 5-6 different study sites (consisting of one coordinator and 3 therapists) will be included. Exclusion criteria are psychosis, substance abuse, and organically based symptoms. Patients are interviewed before treatment and one year after termination, and self-rated outcome measures are filled in at 3-month intervals during treatment and at termination. After an initial evaluation, patients are randomized to one of two manualized psychodynamic group psychotherapies with different treatment lengths (20 and 80 sessions). Each therapist will conduct both a short- and a long-term group, and sessions are taped in order to check treatment integrity.

Condition Intervention Phase
Mood Disorders Anxiety Disorders Personality Disorders Behavioral: short-term dynamic therapy Behavioral: long-term dynamic therapy Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Study of the Efficacy of Analytic Oriented Group Psychotherapy for Psychiatric Outpatients

Further study details as provided by Steinar Lorentzen, University of Oslo:

Primary Outcome Measures:
  • scl-90-R, IIP-C, GAF [ Time Frame: before and after therapy,follow-up and every 3 months during therapy ]

Estimated Enrollment: 140
Study Start Date: August 2005
Estimated Study Completion Date: August 2020
Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: short-term dynamic therapy
Group therapy 20 sessions, give insight
Behavioral: short-term dynamic therapy
Active Comparator: long-term dynamic therapy
Group therapy 80 sessions, give insight
Behavioral: long-term dynamic therapy

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who consult or are referred to oupatient psychiatric centers or private pratice, and who are considered suitable for ambulant psychodynamic group psychotherapy.

Exclusion Criteria:

  • Active psychotic disorder, drug or alcohol dependence as main diagnosis, organically based symptoms, e.g. brain damage, autism and adult ADHD.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00521417


Locations
Norway
Distriktpsykiatrisk senter Helse sunnmøre
Ålesund, Norway, 6014
Sponsors and Collaborators
University of Oslo
Brigham Young University
Investigators
Study Director: Steinar Lorentzen, Dr. med. Associate Professor University of Oslo
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Steinar Lorentzen, professor emeritus, University of Oslo
ClinicalTrials.gov Identifier: NCT00521417     History of Changes
Other Study ID Numbers: aker2004-77
First Submitted: August 24, 2007
First Posted: August 27, 2007
Last Update Posted: May 2, 2016
Last Verified: April 2016

Keywords provided by Steinar Lorentzen, University of Oslo:
RCT

Additional relevant MeSH terms:
Disease
Anxiety Disorders
Mood Disorders
Personality Disorders
Pathologic Processes
Mental Disorders